PropertyValue
?:definition
  • Molecular assay reagents intended to identify gene variants associated with catecholaminergic polymorphic ventricular tachycardia, a ventricular tachycardia characterized by episodic syncope (i.e., fainting) and the absence of structural heart defects. Genetic variants at multiple loci have been associated with catecholaminergic polymorphic ventricular tachycardia. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, single nucleotide polymorphisms) in multiple catecholaminergic polymorphic ventricular tachycardia-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4286604_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4286604_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all